Completed PHASE1 INTERVENTIONAL 3-arm NCT02780752

A Study of Oral Hymecromone and Hyaluronan Synthesis

Dose Ranging Studies of Oral Hymecromone on Hyaluronan Synthesis

Sponsor: Paul Bollyky

Interventions hymecromone

Updated 9 times since 2017 Last updated: Jun 11, 2021 Started: Dec 1, 2020 Primary completion: May 10, 2021 Completion: May 10, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy and Respiratory Disease, this trial is completed. The trial is conducted by Paul Bollyky and has accumulated 9 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Sep 2021 — Jul 2024 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE1

Status: Withdrawn → Recruiting · Phase: PHASE1_PHASE2 → PHASE1
May 2019 — Jan 2021 [monthly]

Withdrawn PHASE1_PHASE2

Status: Not Yet Recruiting → Withdrawn

▶ Show 4 earlier versions

Jun 2018 — May 2019 [monthly]

Not Yet Recruiting PHASE1_PHASE2
Mar 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2
Feb 2017 — Mar 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Paul Bollyky

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Palo Alto, United States